Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
VYNE Therapeutics Inc (NASDAQ: VYNE) closed the day trading at $0.35 down -3.47% from the previous closing price of $0.37. In other words, the price has decreased by -$3.47 from its previous closing price. On the day, 2.94 million shares were traded.
Ratios:
For a better understanding of VYNE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.47 and its Current Ratio is at 4.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On November 18, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 15 ’25 when LEPORE PATRICK G bought 15,000 shares for $2.92 per share. The transaction valued at 43,800 led to the insider holds 51,472 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 9.80 while its Price-to-Book (P/B) ratio in mrq is 0.13.
Stock Price History:
Over the past 52 weeks, VYNE has reached a high of $4.30, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is -68.83%, while the 200-Day Moving Average is calculated to be -82.67%.
Shares Statistics:
A total of 15.96M shares are outstanding, with a floating share count of 13.63M. Insiders hold about 18.19% of the company’s shares, while institutions hold 36.80% stake in the company.
